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While the pathogenic mechanisms of Parkinson's disease (PD)
remain elusive, increasing evidence suggests that neurodegeneration
in PD is associated with impaired mitochondrial ‘quality control’ — an
imbalance between biogenesis and removal by autophagy. PD has
also been associated with impaired mitochondrial complex I activity
and complex I inhibitors like the neurotoxin rotenone cause
pathological and neurochemical changes with a remarkable similarity
to PD [1]. Rosiglitazone is a member of thiazolidinediones (TZDs),
used clinically as insulin-sensitizing drugs. These compounds selec-
tively bind to peroxisome proliferator-activated receptor gamma
(PPARg) a nuclear receptor and ligand-dependent transcription factor
that regulates the expression of several genes involved in lipid
and carbohydrate metabolism, upregulates antioxidant defences and
promotes mitochondrial biogenesis and has anti-inﬂammatory
properties [2]. PPARg agonists provide protection in several in vitro
and in vivo models of neurodegenerative disorders [3,4], but the
mechanism of protection is not clear. We have studied whether
rosiglitazone prevents mitochondrial damage of differentiated
human neuroblastoma SH-SY5Y cells exposed to rotenone and have
explored the interaction of biogenesis, autophagy and oxidative stress
pathways in neuroprotection. Our data show that chronic partial
inhibition of complex I in differentiated SH-SY5Y cells by rotenone
decreases mitochondrial mass and membrane potential, while
increasing autophagy and free radical generation. All these changes
were reversed by co-treatment of the cells with rosiglitazone, which
increased mitochondrial biogenesis and decreased autophagy and
free radical generation. Our data indicate that rosiglitazone is
potentially neuroprotective, acting directly on mitochondrial function
in neurons, and not indirectly by suppressing inﬂammation, and
might provide a valuable therapeutic strategy for the treatment of
progressive neurodegenerative disease such as Parkinson's disease.
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The respiratory chain of mitochondria produces the main amount
of the cellular ATP. To maintain the function of this machinerymost of
its proteins have to be imported into mitochondria after their
synthesis in the cytosol. Although most soluble mitochondrial
proteins contain a mitochondrial targeting signal (MTS), many of
the proteins of the IMS do not contain a MTS but instead are imported
by an oxidative folding mechanism [1,2]. Examples of such proteins
are the so called twin-CX9C proteins that contain four conserved
cysteines. After translocation into the IMS two intramolecular
disulﬁde bonds are formed which contribute to the correct folding
and the retention of the proteins [3]. The machinery that facilitates
oxidation is composed of two main components, the essential
disease-related proteins Mia40 and ALR. Mia40 is an oxidoreductase
that interacts with the reduced and unfolded substrate proteins
and oxidizes them. Mia40 is reduced after this reaction, and it is
subsequently regenerated by ALR [4]. This pathway has so far been
almost exclusively characterized in yeast cells and on isolated
mitochondria. We aim to characterize the pathway and its regulation
in intact mammalian cells. In our experiments we could verify
the importance of Mia40 and ALR for import and assembly of proteins
of the twin-CX9C-family in intact cells. Surprisingly the import
machinery of Mia40 and ALR is quite robust and unaffected by
several mitochondrial stress conditions like the inhibition of respira-
tory chain complexes and limited oxygen availability. However,
contrary to in vitro data, the oxidative protein import depends on
the membrane potential; exhibiting similarities to the MTS-dependent
protein import. Despite the dependence on the proton gradient, both
import pathways exhibit signiﬁcant differences in the kinetics of
import. Import and processing of MTS-containing proteins is a fast
process that occurs co-translationally or in a very fast posttranslational
manner. Conversely, the substrates of Mia40 remain soluble in the
cytosol after synthesis, and are imported in a slow process that is
limited by the rate of Mia40-mediated oxidation.
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Mitochondria still possess some features telling of their
endosymbiontic origin like their own DNA and ﬁssion/fusion
machineries. As the cell grows and increases its size, the need for
energy feeds back via nuclear transcription regulation in order to
upregulate genes involved in mitochondrial biogenesis [1]. As more
than 99% of all mitochondrial proteins are encoded in the nucleus,
they are translated on cytosolic ribosomes and post-translationally
imported into the organelle. This process starts at an essential protein
complex in the outer membrane of mitochondria, called Translocase
of the Outer Membrane or TOM complex [2].
In a recent study [3] we identiﬁed several phosphorylated residues
in this complex and found that mitochondria are muchmore subjected
to cellular signalling cascades than previously thought [4,5]. Themitotic
state of the cell is reﬂected in the activity of cyclin-dependent kinases
(CDK), and indeed, at least one TOM protein has been identiﬁed as a
target for this group.
This study now focuses on the role of CDK-dependent phosphory-
lation of Tom. We demonstrate that the yeast CDK phosphorylates
Tom6 speciﬁcally during the M Phase of the cell cycle. This phosphor-
ylation inﬂuences the TOM complex composition under conditions,
when mitochondrial biogenesis needs to be stimulated.
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Mutations in SURF1 gene leading to loss of an assembly protein
Surf1 are frequent cause of severe defects of cytochrome c oxidase
(COX). Clinical manifestation of these mutations is Leigh syndrome —
a fatal neurodegenerative disease. Surf1 appears to be involved in an
early step of COX assembly but its exact function remains unknown.
In our study we focused on alteration of COX assembly process as a
consequence of SURF1 mutations, on differences in supercomplex
(SC) formation due to decreased amount of COX, and how SURF1
mutations inﬂuence protein and transcript levels of oxidative-
phosphorylation system (OXPHOS) and other pro-mitochondrial
genes. For experiments we used ﬁbroblast cell lines from 9 patients
with different SURF1 gene mutations and control cells. Proteins
solubilised from inner mitochondrial membrane withmild detergents
were analyzed using blue native electrophoresis in combination with
SDS PAGE and Western blot detection. Transcript levels were
determined with Agilent 44 k human genome microarray technique.
Decreased COX level (to 30%) in patient's mitochondria was
accompanied with upregulation of complexes I, III and V (130–150%)
and accumulation of Cox5a subunit. Whole genome expression
proﬁling showed general decrease of transcriptional activity
in patient's cells and indicated that observed changes in OXPHOS
complexes have to be due to posttranscriptional compensatory
mechanisms.
Fully assembled and functional COXwaspresentmainly in I–III2–IV SC
in patient mitochondria, while in control mitochondria the content of
COX in SCs was comparable to that of free COXmonomer. Lack of COX
in patients further led to accumulation of basic I–III2 SC form, complex
III dimer and COX assembly intermediates. Using 2D electrophoresis
we identiﬁed two comigrating COX assembly intermediates in the
85–130 kDa region. One was the originally proposed S2 intermediate
consisting of Cox1, 4, and 5a subunits and the other one contained
large amount of Cox1 subunits. It could represent Cox1 associated
with other unknown proteins but almost no Cox4 and Cox5a
subunits. Both intermediates were completely unable to associate
with complexes I and III into SCs [1].
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The NADH:ubiquinone oxidoreductase is the ﬁrst and largest
complex of the mitochondrial respiratory chain. Its assembly involves
subunits encoded by the mitochondrial as well as the nuclear genome
and requires biogenesis factors, which are not part of the mature
complex I. Pentatricopeptide repeat (PPR) proteins are known to be
involved in various steps of gene expression in organelles [1]. Eight
genes encoding PPR proteins are found in Neurospora crassa
(N. crassa). We determined the relevance of these genes for the
assembly of complex I by characterizing the corresponding knockout
mutants obtained by a high-throughput programme [2]. The
identiﬁcation of complex I defects was accomplished by measuring
the NADH:ferricyanide redox activity and Blue Native polyacrylamide
gel electrophoresis. Two knockout mutants were speciﬁcally affected
in the assembly of complex I. The presence of a peripheral arm and
the absence of a detectable membrane arm were demonstrated.
Assembly intermediates were detected by western blot analysis using
speciﬁc polyclonal antibodies against different complex I subunits.
Moreover, a speciﬁc inﬂuence of the PPR proteins on processing
respectively on amounts of mitochondrial RNA was observed
by means of Northern Blots. To characterize their speciﬁc impact
on biogenesis of complex I, the two proteins were expressed
heterologously in Escherichia coli (E. coli) and puriﬁed via
immobilized metal ion afﬁnity chromatography (IMAC) and size
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